| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 67.365 | 67.304 | 68.571 | 67.089 | 46.701 | 83.652 | 94.571 | 94.441 | 295.758 |
| Total Income - EUR | - | 67.365 | 67.304 | 68.571 | 67.089 | 48.415 | 87.897 | 94.571 | 99.293 | 295.764 |
| Total Expenses - EUR | - | 37.312 | 50.305 | 38.807 | 44.253 | 45.027 | 59.284 | 69.210 | 93.321 | 286.255 |
| Gross Profit/Loss - EUR | - | 30.053 | 16.999 | 29.764 | 22.836 | 3.387 | 28.614 | 25.362 | 5.972 | 9.510 |
| Net Profit/Loss - EUR | - | 28.709 | 16.325 | 29.078 | 22.192 | 2.959 | 27.848 | 24.515 | 5.133 | 8.108 |
| Employees | - | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 3 |
Check the financial reports for the company - Novoimplant Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 112 | 110 | 108 | 106 | 13.880 | 11.877 | 10.214 | 11.616 | 35.701 |
| Current Assets | - | 32.292 | 17.529 | 32.205 | 22.272 | 15.452 | 21.888 | 22.206 | 17.168 | 73.474 |
| Inventories | - | 7 | 1.121 | 1.100 | 14.608 | 2.999 | 8.781 | 5.177 | 2.597 | 12.215 |
| Receivables | - | 7.610 | 1.661 | 1.716 | 2.854 | 2.902 | 3.050 | 3.875 | 13.589 | 57.412 |
| Cash | - | 24.674 | 14.748 | 29.389 | 4.810 | 9.551 | 10.057 | 13.153 | 982 | 3.848 |
| Shareholders Funds | - | 28.753 | 16.369 | 34.402 | 22.234 | 24.772 | 29.662 | 24.556 | 14.237 | 18.684 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 3.650 | 1.270 | -2.089 | 144 | 4.560 | 4.103 | 7.864 | 14.947 | 90.752 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Novoimplant Srl